Web9. jan 2024 · Definition / general. Hypertrophic cardiomyopathy (HCM) is defined by the presence of increased left ventricular (LV) wall thickness (in a non dilated chamber) that is not solely explained by abnormal loading … Web18. feb 2024 · Pediatric hypertrophic cardiomyopathy (HCM) is the most common form of cardiomyopathy in children and a leading cause of sudden cardiac death. ... Furthermore, genetic variation can impact the form and function of the heart beyond just ventricular hypertrophy, and these phenotypes have a complex relationship in their impact of SCD …
Gene: TULP3 (Hypertrophic cardiomyopathy)
Web• The phenotypic variability of HCM expands beyond myocardial hypertrophy, to include morphological and functional manifestations, ranging from subtle anomalies to … Web17. jan 2024 · Limited data is available on phenotypic variations with the same genotype in hypertrophic cardiomyopathy (HCM). The present study aims to explore the relationship between genotype and phenotype ... lithium levels maintenance therapy
Overlap phenotypes of the left ventricular noncompaction and ...
Web24. nov 2024 · Background: The left ventricular noncompaction cardiomyopathy (LVNC) is a rare subtype of cardiomyopathy associated with a high risk of heart failure (HF), … Web20. apr 2024 · The diagnosis and prognosis of hypertrophic cardiomyopathy (HCM) is generally clarified by noninvasive imaging, including screening by echocardiography and often refinement by cardiac magnetic resonance (CMR). ... Hinojar R, Varma N, Child N, et al. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease … Myocardial hypertrophy can occur as a result of a variety of cardiac and systemic diseases, such as hypertensive heart disease, amyloidosis and Anderson-Fabry disease [8, 63,64,65]. Systemic hypertension can lead to concentric LV hypertrophy, and discriminating between HCM and hypertensive heart … Zobraziť viac The distribution of myocardial hypertrophy is extremely variable. Cardiac MRI is particularly useful for characterising the location and … Zobraziť viac In HCM, reduced ventricular volumes are frequent and the hyperkinetic appearance of systolic contraction translates into a normal or supernormal ejection fraction (EF) (> 65%) until the end-stage of the disease [8]. EF is, … Zobraziť viac LVOT obstruction is present in 70% of classic HCM phenotype patients and is associated with an increased risk for heart failure-related death [2, 8]. The mechanisms … Zobraziť viac Abnormalities in the morphology and function of the mitral valve apparatus are now considered a phenotypic expression of HCM that is … Zobraziť viac lithium levels monitoring